The Use of Methylene Blue during Liver Transplantation for Vasoplegia

Paul Harding, Thomas Nicholas, Cale Kassel

Research output: Contribution to journalArticlepeer-review

Abstract

The use of methylene blue for vasoplegia in cardiac cases with cardiopulmonary bypass, septic shock, and acute liver failure is well documented. Use of MB for liver transplantation has been largely limited to case reports. We describe three separate liver transplantation patients with significant hypotension following reperfusion. Administration of methylene blue to each patient resulted in a significant decrease in vasopressor medication and two patients weaned completely. We argue that the use of MB should be considered as a treatment option for refractory hypotension.

Original languageEnglish (US)
Article number6610754
JournalCase Reports in Anesthesiology
Volume2021
DOIs
StatePublished - 2021

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Fingerprint

Dive into the research topics of 'The Use of Methylene Blue during Liver Transplantation for Vasoplegia'. Together they form a unique fingerprint.

Cite this